Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AALLON GROUP OYJ AALLON Apr 20, 2021 11.55 -2.12   
 Admicom Oyj ADMCM Apr 20, 2021 94.50 -2.58   
 Afarak Group AFAGR Apr 20, 2021 0.22 -0.45   
 Ahlstrom-Munksj÷ AM1 Apr 20, 2021 17.74 -0.11   
 Ahola Transport AHOLA Apr 20, 2021 1.76 0.00   
 Aktia Bank AKTIA Apr 20, 2021 10.20 -1.54   
 Alma Media ALMA Apr 20, 2021 10.08 -3.08   
 Altia ALTIA Apr 20, 2021 10.96 +1.29   
 Apetit APETIT Apr 20, 2021 13.60 -0.37   
 Aspo ASPO Apr 20, 2021 8.89 -0.34   
 Aspocomp Group ACG1V Apr 20, 2021 4.16 -2.80   
 Atria A ATRAV Apr 20, 2021 12.66 -0.32   
 Basware BAS1V Apr 20, 2021 37.00 -5.25   
 BBS-Bioactive Bone Substitutes BONEH Apr 20, 2021 3.47 0.00   
 Bilot Plc BILOT Apr 20, 2021 7.78 -0.26   
 Biohit B BIOBV Apr 20, 2021 2.20 +1.38   
 Bittium BITTI Apr 20, 2021 6.65 -1.92   
 Boreo Oyj BOREO Apr 20, 2021 47.50 -2.26   
 CapMan CAPMAN Apr 20, 2021 2.54 -0.97   
 Cargotec CGCBV Apr 20, 2021 46.90 -3.22   
 Caverion CAV1V Apr 20, 2021 5.50 -1.43   
 Citycon CTY1S Apr 20, 2021 7.30 +0.07   
 Componenta CTH1V Apr 20, 2021 4.08 -0.24   
 Consti Plc CONSTI Apr 20, 2021 13.35 +0.75   
 Detection Technology DETEC Apr 20, 2021 27.60 +0.73   
 Digia DIGIA Apr 20, 2021 7.90 -1.25   
 Digitalist Group DIGIGR Apr 20, 2021 0.05 +1.63   
 Dovre Group DOV1V Apr 20, 2021 0.43 +0.23   
 EAB Group EAB Apr 20, 2021 3.70 -1.33   
 Eezy Oyj EEZY Apr 20, 2021 5.62 -2.43   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK